The incidence of Mycoplasma pneumoniae in community acquired pneumonia among children: one centre study

Abstract

Background: Mycoplasma pneumoniae (M. pneumoniae) is an important cause of pediatric community acquired pneumonia (CAP). Aim: The aim of this study was to determine the incidence of M. pneumoniae in pediatric community acquired pneumonia and to determine the most frequent clinical findings of M. pneumoniae CAP. Methods: A total of 83 pediatric CAP patients were subjected to history taking, clinical examination, chest X-ray, CBC, CRP and serum antimycoplasma pneumonia IgM and IgA by ELISA. Results: Twenty-nine (34.9%) out of 83 patients were positive for M. pneumoniae Ig M while 2 (3.4%) patients were positive for M. pneumoniae IgA. There was more infection (54%) in age group (5-9 years; p value <0.001). Mycoplasma pneumoniae pneumonia infected patients were presented with cough (29/29; 100%), fever (29/29; 100%), malaise (18/29; 43.8%), headache (16/29; 33.8%), wheeze (21/29; 52.5%), chest discomfort (13/29; 44.8%), sore throat (13/29; 46.4%), rhinitis (8/29; 27.5%) and pharyngitis (6/29; 24%). The most frequent X ray findings in M. pneumoniae pneumonia was air space pneumonia (71%); segmental more than lobar form (p-value < 0.0001). Conclusions: The findings of this study highlight the clinical significance of M pneumoniae in pediatric community acquired pneumonia.

Clinical characteristics and changes in serum CXCL10 and CXCL16 levels in patients with severe mycoplasma pneumonia

“…Analyzing the atypical pathogen of the child, mycoplasma pneumonia (MP) is an important pathogen of CAP in the child. [4][5][6] MP can cause mycoplasma pneumoniae pneumonia (MPP). The incidence rate accounts for 10% to 40% of the hospitalized children with CAP.…”